January 5, 2021 Paustenbach and Asssociates On November 23, 2021, the FDA announced that Proctor & Gamble Company had voluntarily
November 24, 2021 Paustenbach and Asssociates On October 29, 2021, the Centers for Disease Control (CDC) released a report discussing
October 19, 2021 Paustenbach and Asssociates Over the past 3 years, there has been renewed interest in identifying products which
October 19, 2021 Paustenbach and Asssociates What was found in Varenicline? In 2021, the FDA recalled certain batches of varenicline,
October 25, 2021 Paustenbach and Asssociates I’m very happy to announce that Paustenbach and Associates is opening a new office
September 27, 2021 Paustenbach and Asssociates What Is the Significance of the Recall of the Philips Respironics Ventilators, BiPAP, and
September 27, 2021 Paustenbach and Asssociates EPA Chlorpyrifos Summary What is Chlorpyrifos? Chlorpyrifos has been in use since 1965 and
July 6, 2021 Paustenbach and Asssociates Executive Summary Paraquat litigation occurred about 30 years ago which focused on acute
Summary In June 2020, Mark Zellmer published a “Perspectives” paper in this journal titled “Chrysotile and the EPA: Part of
What is acrylamide and how does it end up in foods? When certain carbohydrate-rich foods are processed at temperatures higher
Paustenbach and Associates (2020) Background In March 2020, EPA published a Draft Risk Evaluation for Asbestos (Docket EPA-HQ-OPPT-2019-0501) in
COVID-19 Offering Expert Guidance Offering Expert Guidance Paustenbach and Associates is actively helping clients manage and mitigate risk associated with
© 2020 All rights reserved